Advertisement

Topics

Bio-Tissue Announces First Study to Demonstrate Corneal Nerve Regeneration in Patients with Dry Eye Disease with the Use of PROKERA

15:14 EST 9 Nov 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
- Company’s Proprietary Cryopreserved Amniotic Membrane Continues to Advance Treatment of the Ocular Surface - Bio-Tissue, Inc., a business unit of TissueTech, Inc., announced today the publication of “Corneal Nerve Rege...

Other Sources for this Article

Bio-Tissue
Media Contacts:
Silvana Guerci-Lena, 508-808-8993
sguercilena@biotissue.com

NEXT ARTICLE

More From BioPortfolio on "Bio-Tissue Announces First Study to Demonstrate Corneal Nerve Regeneration in Patients with Dry Eye Disease with the Use of PROKERA"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...

Pain
Pain is defined by the International Association for the Study of Pain as “an unpleasant sensory and emotional experience associated with actual or potential tissue damage or described in terms of such damage”. Some illnesses can be excruci...